Picture of Cellectis SA logo

ALCLS Cellectis SA Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for Cellectis SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-125-98.7-117-36.8-67.6
Depreciation
Non-Cash Items7.15-2.7120.7-19.841.7
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.18-4.4852.959.7-33.6
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-105-87.4-24.723-39.4
Capital Expenditures-19.7-2.44-1.07-3.84-3.53
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items27-0.32-14.4-99-26
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities7.28-2.76-15.5-103-29.5
Financing Cash Flow Items44.58.321.45-0.847-0.612
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities47.51.1582.989.1-16.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-55.5-92.443.56.54-81.7